If you like $2 biotechs I suggest you look at TGEN---already has products in Phase II trials plus partnerships with big pharma, sound balance sheet-----current price is simply the result of market distractions not relevant to their future prospects-----regards---bababa booooooom
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.